申请人:ARDELYX INC
公开号:WO2013096771A1
公开(公告)日:2013-06-27
Compounds of structure (I), or a stereoisomer, tautomer, pharmaceutically acceptable salt or prodrug thereof, wherein R1, R2, R3, R4, R8, R9, R10, R11, R12, A1, A2, X, Y and Z are as defined herein. Uses of such compounds as TGR5 antagonists and for treatment of various indications, including Type II diabetes meletus are also provided.
结构(I)的化合物,或其立体异构体、互变异构体、药学上可接受的盐或前药,其中R1、R2、R3、R4、R8、R9、R10、R11、R12、A1、A2、X、Y和Z如本文所定义。提供了这些化合物作为TGR5拮抗剂的用途,以及用于治疗各种适应症,包括II型糖尿病。